EPISODE · Feb 18, 2026 · 6 MIN
Ocular Releases Phase 3 Data for Wet AMD Candidate Axpaxli
from Eyewire News: The Podcast · host Eyewire News
Ocular Therapeutix releases its long-awaited SOL-1 phase 3 data for wet AMD drug candidate Axpaxli; Nordic Pharma expands the availability of its novel dry eye therapy Lacrifill; and Alcon launches the only multifocal toric contact lens featuring Water Gradient Technology. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Ocular Releases Phase 3 Data for Wet AMD Candidate Axpaxli
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m